Jim Cramer
Palo Alto shares helped by contract news, Abbott Labs braces for lawsuit ruling
Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just in time for the last hour of trading on Wall Street. Markets: Wall Street is under pressure Thursday, led to the downside by the tech-heavy Nasdaq Composite , which dropped more than 2%. The S & P […]
Read More
We’re hiking our GEHC price target, looking beyond a mixed quarter to next year’s catalysts
GE Healthcare reported a mixed quarter before Wednesday’s opening bell. While revenue slightly missed, an earnings beat along with a number of other positives pushed the stock higher. Revenue rose just under 1% year over year to $4.86 billion in the third quarter, just short the $4.87 billion expected, according to analyst estimates compiled by […]
Read More
Danaher returns a key business to growth, and we’re raising our stock rating back to buy
Danaher shares declined Tuesday despite the life sciences company returning its key bioprocessing business to growth in the third quarter. Danaher’s revenue for the three months ended Sept. 27 advanced 3% year over year on a reported basis, to $5.8 billion, outpacing the LSEG consensus estimate of $5.59 billion. On an organic basis, sales were […]
Read More
After a well-received quarter, Cramer explains why he thinks Netflix can ‘rock on higher’
After a siding with the bulls in the run-up to Netflix‘s latest earnings report, CNBC’s Jim Cramer explained why the quarter made him more optimistic about the company’s future, saying he was impressed by management’s outlook and commentary about content. “If you were worried about Netflix not having enough levers to pull in order to […]
Read More
Embattled Abbott Labs comes through with a strong quarter, buyback announcement
Medical device maker Abbott Laboratories on Wednesday delivered better-than-expected quarterly results and upped its earnings guidance for the third straight quarter. Shares rose more than 1%, shaking off an initially subdued reaction. Revenue in the three months ended Sept. 30 rose 4.9% to $10.64 billion, topping estimates of $10.55 billion, according to data provider LSEG. […]
Read More
Jim Cramer’s week ahead: CPI data and earnings from Delta, Domino’s and major banks
CNBC’s Jim Cramer reviewed next week’s top market-moving action, highlighting new consumer price index data and a slew of earnings reports as the season begins, including ones from Delta, Domino’s and several major banks. He also noted the stocks rally on Friday as Wall Street celebrated better-than-expected job creation last month. “A market that appreciates […]
Read More
GE Healthcare has been an under-the-radar winner — and a new catalyst just arrived
GE Healthcare ‘s quiet outperformance is becoming harder to tune out — and its new drug used in radiology to improve the diagnosis of heart disease can help the Club stock make some more noise. In a note to clients Sunday, Wells Fargo analysts said that GE Healthcare’s diagnostic agent Flyrcado is “possibly the most […]
Read More
10 things to watch in the stock market Friday including a bullish call on Best Buy
10 things to watch Friday, Sept. 27 1. The S & P 500 was looking at a slightly higher open Friday after another record high close. The 10-year Treasury yield was finally lower following a tame August reading on the Fed’s favorite inflation gauge, the PCE price index. With just a couple trading days left […]
Read More
Why Eli Lilly and Palo Alto Networks are both up on news from their competitors
Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just in time for the last hour of trading on Wall Street. Markets: The Dow and S & P 500 were lower Friday after surging to record highs Thursday in response to the Fed cutting interest rates by […]
Read More
3 ways Wall Street’s largest banks are leveraging AI to increase profitability
Big banks are jumping headfirst into the AI race. Over the past year, Wall Street’s largest names — including Goldman Sachs , Bank of America , Morgan Stanley , Wells Fargo to JPMorgan Chase — ramped up their generative artificial intelligence efforts with the aim of boosting profits. Some are striking deals and partnerships to […]
Read More